Title:
機能的に選択されたＣＴＬ細胞およびＮＫ細胞の診断的および治療的応用
Document Type and Number:
Japanese Patent JP5401307
Kind Code:
B2
Abstract:
The invention proposes a novel therapeutic and diagnostic methodology based on the use of effector cells (for example CTL and NK cells) selected for being able to induce lysis in target cells. In particular, the invention teaches how to select strains of effector cells of the immune system according to their lytic properties. It also teaches how diagnostic procedures for checking the activity of therapeutic vaccines can be improved with respect to what shown. Finally, it shows how cell therapies used at present can be improved by using this approach.
Inventors:
ギャンバリ Roberto
Guerrieri Roberto
Guerrieri Roberto
Application Number:
JP2009504846A
Publication Date:
January 29, 2014
Filing Date:
April 12, 2007
Export Citation:
Assignee:
Silicon bio-systems S. Py. Ey. SILICON BIOSYSTEMSS. P. A.
ギャンバリ Roberto GAMBARI and Roberto
ギャンバリ Roberto GAMBARI and Roberto
International Classes:
C12Q1/02; A61K39/395; A61P37/02; C12M1/00; C12N5/078
Attorney, Agent or Firm:
Patent business corporation Akinari international patent firm